A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients
Scott C. Lester(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), Jaden D. Evans(Mayo Clinic), Minesh P. Mehta(Columbia University), Andrea Arnett(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Neha Bhooshan(University of Maryland, Baltimore), Michael G. Haddock(Mayo Clinic in Arizona), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), Grant M. Spears(Mayo Clinic in Florida), Sarah E. James(Mayo Clinic), Michael D. Chuong(Baptist Hospital of Miami)
International Journal of Radiation Oncology*Biology*Physics
February 21, 2017
Cited by 40
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k